Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alkaloids, Belladonna
2. Belladonna Alkaloids
1. Belladonnine Sulfate
2. 510-25-8
3. Beta-belladonnine
4. Belladonna Alkaloids
5. Nsc100797
6. 5878-33-1
7. Schembl6437603
8. Chembl3187149
9. Dtxsid10965277
10. Stk663541
11. Ncgc00160302-01
12. Bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 4-phenyl-2,3-dihydro-1h-naphthalene-1,4-dicarboxylate
13. Ncgc00160302-01!belladonnine
14. Ft-0622610
15. Bis(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 1-phenyltetralin-1,4-dicarboxylate
16. 1,2,3,4-tetrahydro-1-phenyl-1,4-naphthalenedicarboxylic Acid Bis(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) Ester
17. Bis(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 1-phenyl-1,2,3,4-tetrahydronaphthalene-1,4-dicarboxylate
18. Sulfuric Acid Compound With Bis(8-methyl-8-azabicyclo[3.2.1]oct-3-yl) 1-phenyl-1,2,3,4-tetrahydro-1,4-naphthalenedicarboxylate (1:1)
Molecular Weight | 542.7 g/mol |
---|---|
Molecular Formula | C34H42N2O4 |
XLogP3 | 6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 7 |
Exact Mass | 542.31445783 g/mol |
Monoisotopic Mass | 542.31445783 g/mol |
Topological Polar Surface Area | 59.1 Ų |
Heavy Atom Count | 40 |
Formal Charge | 0 |
Complexity | 922 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 6 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03B - Belladonna and derivatives, plain
A03BA - Belladonna alkaloids, tertiary amines
A03BA04 - Belladonna total alkaloids
NDC Package Code : 63570-010
Start Marketing Date : 2000-03-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1120
Start Marketing Date : 2013-06-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.
About the Company : Alchem International, established in 1935, is a pioneer in phytochemicals, providing plant-derived active pharmaceutical ingredients to the pharmaceutical, cosmetic and nutraceutic...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Inga Pharmaceuticals (Inga), established in 1980, is involved in the cultivation, isolation and extraction of actives from plant sources. The Corporate Office is located in Mumbai ...
About the Company : Ransom Naturals Ltd (RNL) is a leading developer and manufacturer of natural products and extracts to the pharmaceutical, cosmetic and food & drinks industries.Our range includes a...
Market Place
ABOUT THIS PAGE
A Belladonna Leaf Extract manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Belladonna Leaf Extract, including repackagers and relabelers. The FDA regulates Belladonna Leaf Extract manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Belladonna Leaf Extract API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Belladonna Leaf Extract manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Belladonna Leaf Extract supplier is an individual or a company that provides Belladonna Leaf Extract active pharmaceutical ingredient (API) or Belladonna Leaf Extract finished formulations upon request. The Belladonna Leaf Extract suppliers may include Belladonna Leaf Extract API manufacturers, exporters, distributors and traders.
click here to find a list of Belladonna Leaf Extract suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Belladonna Leaf Extract as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Belladonna Leaf Extract API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Belladonna Leaf Extract as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Belladonna Leaf Extract and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Belladonna Leaf Extract NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Belladonna Leaf Extract suppliers with NDC on PharmaCompass.
Belladonna Leaf Extract Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Belladonna Leaf Extract GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Belladonna Leaf Extract GMP manufacturer or Belladonna Leaf Extract GMP API supplier for your needs.
A Belladonna Leaf Extract CoA (Certificate of Analysis) is a formal document that attests to Belladonna Leaf Extract's compliance with Belladonna Leaf Extract specifications and serves as a tool for batch-level quality control.
Belladonna Leaf Extract CoA mostly includes findings from lab analyses of a specific batch. For each Belladonna Leaf Extract CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Belladonna Leaf Extract may be tested according to a variety of international standards, such as European Pharmacopoeia (Belladonna Leaf Extract EP), Belladonna Leaf Extract JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Belladonna Leaf Extract USP).
LOOKING FOR A SUPPLIER?